We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Securities and Exchange Commission faults ride-hailing app for failing to disclose role of director in deal
Carl Icahn is under pressure from short sellers, and his own bets
Move follows short seller Hindenburg Research saying large payouts are unsustainable
Billionaire investor pledges more collateral in deal with five lenders
Chief’s resignation follows chair’s departure from gene sequencing group
The veteran investor has seen bets against a fast-rising market turn sour
Vote to remove John Thompson is the culmination of one of the largest shareholder activism campaigns in years
Gene sequencing company heads for pivotal vote in battle with activist investor Carl Icahn
Plus, Credit Suisse bondholders get access to AT1 wipeout decree and Geely boosts stake in Aston Martin
‘If I kept the parameters I always believed in . . . I would have been fine,’ concedes activist
Jefferies! Hindenburg! Blitzkrieg! Schadenfreude!
Proxy adviser says the two executives failed to take responsibility for destructive deal for Grail
Shares plummet on news US attorney’s office sought information a day after report from short seller Hindenburg Research
Activist investor strongly denies Hindenburg allegations but he may have a more immediate problem
Legendary activist investor’s vehicle said to be overvalued in critical report
Oh, the humanity . . .
Founding directors say political wrangling causing delays to potentially life-saving blood test
Francis deSouza was awarded $26.7mn in total pay last year despite drop in genome sequencer’s market value
Comments by activist investor come ahead of US central bank’s rate-setting meeting next week
Company’s shares jump after activist investor launches proxy battle
Feared to be facing bankruptcy three years ago, oil producer Occidental is set to report its biggest-ever earnings
Plus, Lars Windhorst walks off the pitch and a glimpse into Wall Street’s lucrative tax side-hustle
Billionaire activist had sought two board seats at fast-food chain in campaign to end caging of sows
Fast walking FTW; Carl Icahn; and Elon (again, sigh)
Corporate raider tells us his McDonald’s proxy fight is a vital test case
UK Edition
